During Q3 2018 the big money sentiment increased to 1.05. That’s change of 0.08, from 2018Q2’s 0.97. 43 investors sold all, 748 reduced holdings as JNJ ratio improved. 719 increased positions while 115 funds amassed positions. Funds hold 1.70 billion shares thus 7.91% less from 2018Q2’s 1.84 billion shares. Waverton Mngmt Ltd stated it has 0.11% of its capital in Johnson & Johnson (NYSE:JNJ). 3,200 are held by Legg Mason Asset Mgmt (Japan) Company Ltd. Murphy Pohlad Asset Mngmt Ltd Liability Co invested in 19,112 shs. Highstreet Asset Management Inc accumulated 215,250 shs or 1.65% of the stock. Troy Asset Limited owns 129,274 shs for 0.84% of their capital. Thrivent Fincl For Lutherans owns 1.18 million shs or 0.51% of their US capital. 1,745 were accumulated by Amer Inv Ser Incorporated. Moreover, Hudock Cap Group Inc Limited Company has 0.86% invested in Johnson & Johnson (NYSE:JNJ) for 16,104 shs. Asset Mgmt Grp accumulated 1.1% or 23,586 shs. Freestone Capital Holdings Limited Liability Corp reported 23,572 shs. Stephens Ar reported 177,064 shs. Td Asset Mgmt reported 2.50M shs stake. Beck Capital Mngmt Lc has invested 0.14% in Johnson & Johnson (NYSE:JNJ). Clarkston Capital Lc holds 1.28% in Johnson & Johnson (NYSE:JNJ) or 252,181 shs. Advent Mgmt De stated it has 0.05% in Johnson & Johnson (NYSE:JNJ).
JNJ had 7 selling transactions and 3 insider buys since September 7, 2018. This’s net activity of $75.53 million. On Friday, December 14 MULCAHY ANNE M also bought $100,050 worth of Johnson & Johnson (NYSE:JNJ). On Friday, December 14 PRINCE CHARLES had bought 2,000 shs worth $268,731. $1.23M worth of Johnson & Johnson (NYSE:JNJ) was sold by Kapusta Ronald A. On Wednesday, November 7 Duato Joaquin had sold 40,000 shs worth $5.77 million. On Friday, November 23 a trade for 30,943 shs valued at $4.41 million was made by Sneed Michael E. On Friday, December 14 Shares for $133,910 were bought by PEREZ WILLIAM D.
Daiwa Sb Investments Ltd upped its holdings by 43.71% in Johnson & Johnson (JNJ), according to 2018Q3 Securities and Exchange form. The company’s stock popped up 5.87% while Daiwa Sb Investments Ltd bought 31,600 shares. The major pharmaceuticals company announced $14.36M value for the 2018Q3. Now the institutional investor is holding 103,900 shares, compared to the 72,300 from the previous quarter. $364.40B is Johnson & Johnson’s market cap. JNJ reached $135.87 during the last trading session after $0.24 change.Johnson & Johnson has volume of 4.38M shares. Since February 28, 2018 JNJ has risen 3.75% and is uptrending. The stock outperformed the S&P500 by 3.75%.
For a total of 91,890 shares it reduced its holding in Intel Corp (NASDAQ:INTC) by 70,860 shares in the quarter, and has cut its stake in Broadcom Inc.
For more Johnson & Johnson (NYSE:JNJ) news published briefly go to: Bizjournals.com, Seekingalpha.com, Seekingalpha.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Sightbox CEO on life after acquisition and growth under J&J – Portland Business Journal” published on February 06, 2019, “Johnson & Johnson to acquire Auris Health for $3.4B – Seeking Alpha” on February 13, 2019, “FDA OKs split-dosing regimen for J&J’s Darzalex – Seeking Alpha” with a publish date: February 12, 2019, “Big Pharma’s Showdown With Congress Over Drug Pricing: What It Really Means for You – Nasdaq” and the last “J&J to begin giving drug pricing in TV ads – Seeking Alpha” with publication date: February 07, 2019.
Johnson & Johnson (NYSE:JNJ) Ratings Coverage
Total analysts of 5 have positions in Johnson \u0026 Johnson (NYSE:JNJ) as follows: 3 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 60%. Since October 11, 2018 according to StockzIntelligence Inc Johnson \u0026 Johnson has 9 analyst reports. On Wednesday, October 17 the company was maintained by Raymond James. On Wednesday, January 2 the firm has “Equal-Weight” rating given by Morgan Stanley. In Monday, February 25 report Citigroup maintained it with “Neutral” rating and $147 target. On Monday, January 14 the company was maintained by Wells Fargo. On Monday, October 22 Citigroup maintained Johnson & Johnson (NYSE:JNJ) with “Neutral” rating. On Thursday, October 11 the stock of Johnson & Johnson (NYSE:JNJ) earned “Equal-Weight” rating by Morgan Stanley. On Thursday, February 14 the company was maintained by Credit Suisse. On Wednesday, October 17 the firm has “Outperform” rating given by Credit Suisse. On Wednesday, January 2 Citigroup maintained Johnson & Johnson (NYSE:JNJ) with “Neutral” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.